Financial news on March 16, 2008
Business and Financial news
Cutting Dosage of Costly Drug Spurs a Debate
A drug for a rare enzyme deficiency can cost $300,000 a year, making the right dose a matter of public debate. Read more..
Fed Chief Shifts Path, Inventing Policy in Crisis
Ben S. Bernanke, who has long argued that a central bank should act on consistent principles, now has to improvise. Read more..